Both the Boca and Paladin generics, mostly, are garbage and duplicate what Qualitest is already producing. There is no pipeline and generics are taking over the two flagship branded products. Aveed is a prayer still. And where are they going to come up with the shares for the buyout? They have to put more shares on the market and dilute the share price. It just seems like this is a window for Fidelity and other big holders to get out.